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Abstract
Background:  Endothelium dysfunction is believed to play a role in the development of
cardiovascular disease. The aim of the present study was to evaluate the suitability of organ culture
as a model for endothelium dysfunction.
Methods: The isometric tension was recorded in isolated segments of the rat mesenteric artery
branch, before and after organ culture for 20 h. Vasodilatation was expressed as % of
preconstriction with U46619. The acetylcholine (ACh) induced nitric oxide (NO) mediated
dilatation was studied in the presence of 10 µM indomethacin, 50 nM charybdotoxin and 1 µM
apamin. Endothelium-derived hyperpolarising factor (EDHF) was studied in the presence of 0.1 mM
L-NOARG and indomethacin. Prostaglandins were studied in the presence of L-NOARG,
charybdotoxin and apamin.
Results: The ACh-induced NO and prostaglandin-mediated dilatations decreased significantly
during organ culture (NO: 84% in control and 36% in cultured; prostaglandins: 48% in control and
16% in cultured). Notably, the total ACh-dilatation was not changed. This might be explained by
the finding that EDHF alone stimulated a full dilatation even after organ culture (83% in control and
80% in cultured). EDHF may thereby compensate for the loss in NO and prostaglandin-mediated
dilatation. Dilatations induced by forskolin or sodium nitroprusside did not change after organ
culture, indicating intact smooth muscle cell function.
Conclusions: Organ culture induces a loss in NO and prostaglandin-mediated dilatation, which is
compensated for by EDHF. This shift in mediator profile resembles that in endothelium
dysfunction. Organ culture provides an easily accessible model where the molecular changes that
take place, when endothelium dysfunction is developed, can be examined over time.
Background
Endothelium dysfunction is developed in cardiovascular
diseases such as arteriosclerosis, diabetes, congestive heart
failure, coronary artery disease, stroke and hypertension
(de Meyer & Herman 2000). In conducting arteries, the re-
sponse to endothelium-dependent dilators declines when
endothelium dysfunction is developed mainly due to a
decrease in nitric oxide (NO) release. In resistance arteries,
endothelium-derived hyperpolarising factor (EDHF) is
more abundant and may compensate for the loss in NO
production [1–3].
Acetylcholine (ACh) is commonly used to assess endothe-
lium-dependent dilatation. The dilatory mediators that
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are released by ACh, have so far mainly been characterised
as NO, prostaglandins and EDHF. NO is produced by ni-
tric oxide synthase in endothelial cells and dilates smooth
muscle cells by activating guanylate cyclase [4]. NO pro-
duction can be inhibited with the L-arginine analogue L-
NG-nitroarginine (L-NOARG). Dilatory prostaglandins
are produced by cyclo-oxygenase from arachidonic acid in
endothelial cells and relaxes smooth muscle cells by acti-
vating adenylate cyclase [5]. Prostaglandin formation can
be inhibited with indomethacin, a cyclo-oxygenase inhib-
itor. EDHF is an endothelium-derived mediator, distinct
from NO and prostaglandins, which hyperpolarises and
relaxes smooth muscle cells. Both its dilatory and hyper-
polarising effect can be antagonised by a combination of
the potassium channel inhibitors, charybdotoxin and
apamin, in the rat mesenteric artery [6,7].
Organ culture of intact blood vessel segments has been
suggested as a model for the phenotypic changes in the
smooth muscle cells that occur during the development of
cardiovascular disease [8]. One day of organ culture in-
duces an upregulation of contractile endothelin type B re-
ceptors on smooth muscle cells [9], thereby mimicking
atherosclerosis [10] and coronary artery disease [11]. Or-
gan culture also induces downregulation of the angi-
otensin II receptor contractility (unpublished data),
reflecting the phenotypic changes in heart failure and hy-
pertension [12]. Serotonin type 1B and 1D receptors are
upregulated after organ culture in rat cerebral arteries [13],
which resembles the alterations in smooth muscle cell
function after subarachnoidal haemorrhage [14,15]. So
far, this model for vascular disease has only been applied
to study the phenotypic changes of smooth muscle cells.
In the present work, the phenotypic changes of the en-
dothelium after organ culture were examined for the first
time.
Endothelium dysfunction contributes to the diminished
peripheral blood perfusion in cardiovascular disease. In
order to explore novel therapeutic targets, the underlying
mechanism of endothelium dysfunction needs to be ex-
amined. Difficulties exist due to lack of an easily accessi-
ble experimental model in which it is feasible to follow
the development of endothelium dysfunction and there-
by delineate the mechanisms of action. The aim of the
present study is to evaluate the suitability of organ culture
as a model for endothelium dysfunction.
Methods
Tissue preparation
Female Sprague-Dawley weighing 200 g were anaesthe-
tised by inhalation of CO2, after which they were killed
with a cardiac cut. The superior mesenteric artery was re-
moved gently and immersed in cold oxygenated buffer so-
lution (for composition, se below) and dissected free of
adhering tissue under a microscope. In experiments where
endothelium denudation was required this was per-
formed by perfusion of the vessel for 5 sec with 0.1% Tri-
ton X-100 followed by another 10 sec with a physiologic
buffer solution (for composition, see below). The vessels
were then cut into 1 mm long cylindrical segments and di-
vided into two groups; one that was kept in a 8°C refriger-
ator (control segments) and the other in organ culture for
20 h (cultured segments). The segments for organ culture
were placed in a 48 well plate, one segment in each well,
containing 750 µl Dulbecco's modified Eagle's medium
(DMEM) and incubated at 37°C in humified 5 % CO2 in
air. The DMEM (4500 mg/L D-glucose) was serum-free
and contained sodium pyruvate (110 µg/L) and L-
glutamine (584 mg/L), and was supplemented with peni-
cillin (199 U/mL) and streptomycin (100 µg/mL). For fur-
ther method details, see Adner et al. [9].
Experimental set-up
Each vessel segment was mounted on two L-shaped metal
prongs, one of which was connected to a force displace-
ment transducer (FT03C) for continuous recording of the
isometric tension, and the other to a displacement device
[16]. The position of the holder could be changed by
means of a movable unit allowing fine adjustments of the
vascular resting tension by varying the distance between
the metal prongs. The mounted artery segments were im-
mersed in temperature controlled (37°C) tissue baths
containing a bicarbonate based buffer solution of the fol-
lowing composition (mM): NaCl 119, NaHCO3 15, KCl
4.6, MgCl2 1.2, NaH2PO4 1.2, CaCl2 1.5 and glucose 5.5.
The solution was continuously gassed with 5 % CO2 in O2
resulting in a pH of 7.4. Four control and four cultured
vessel segments were studied at the same time in separate
tissue baths. The artery segments were allowed to stabilise
at a resting tension of 2 mN for 1 h before the experiments
were started. The contractile capacity of each vessel seg-
ment was examined by exposure to a K+-rich (60 mM)
buffer solution in which NaCl was exchanged for an equi-
molar concentration of KCl (for composition, see above).
When two reproducible contractions had been achieved
the vessels were used for further experiments.
Preconstrictors
The efficacy and durability of the contraction elicited by
9,11-Dideoxy-11alpha,9alpha-
epoxymethanoprostaglandinF2alpha (U46619), noradren-
aline and phenylephrine was monitored when the maxi-
mum contraction (Emax) was first obtained, and 10 min
thereafter. The decrease in contraction after 10 min was
expressed as "percent decrease of Emax".
Endothelium dependent dilatation
Dilatory responses were assessed by cumulative addition
of ACh (0.1 nM – 0.1 mM) in arteries with intact endothe-BMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/8
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lium, precontracted with U46619. The concentration of
U46619 was titrated to result in a submaximal precontrac-
tion, amounting to 70 % of maximum. The NO-mediated
dilatation was studied after inhibiting prostaglandins
with 10 µM indomethacin and EDHF with 50 nM charyb-
dotoxin and 1 µM apamin. EDHF was studied in the pres-
ence of the NO synthetas inhibitor L-NOARG (0.1 mM)
and indomethacin. Prostaglandins were studied in the
presence of L-NOARG, charybdotoxin and apamin.
Smooth muscle cell dilatory responses
Endothelium removal was checked by monitoring dilato-
ry responses to ACh after precontraction with U46619.
Abolished relaxation indicated a properly removed en-
dothelium. The smooth muscle function was thereafter
evaluated by cumulative addition of the NO-donor sodi-
um nitropruside (SNP, 0.01 nM – 1 µM) and the ade-
nylate cyclase activator forskolin (0.01 nM – 10 µM).
Ethics
The protocol was approved by the Ethical Committee of
University Hospital (Lund, Sweden).
Drugs
All drugs were purchased from Sigma-Aldrich, USA and
dissolved in 0.9% saline.
Calculations and statistics
Calculations and statistics were performed using the
GraphPad Prism 3.02 software. The negative logarithm of
the drug concentration that elicited 50% contraction or re-
laxation (pEC50) was determined by fitting the data to the
Hill equation. Rmax refers to maximum relaxation calcu-
lated as percentage of the corresponding precontraction
with U46619, while Emax refers to maximum contraction
calculated as percent of the contractile capacity of 60 mM
K+. n denotes the number of experiments that were per-
formed, each in a different animal. Statistical significance
was accepted when P < 0.05, using Student's t-test. All dif-
ferences referred to in the text have been statistically veri-
fied. Values are presented as means ± S.E.M.
Results
The contractile response to 60 mM K+ did not differ be-
tween control (3.4 ± 0.5 mN, n = 14), and cultured vessel
segments (3.6 ± 0.4 mN, n = 14, P = n.s.).
Preconstrictors
The efficacy of the phenylephrine and noradrenaline con-
tractions consecutively decreased over time. 10 min after
the maximum response was first obtained, the efficacy of
the contraction had decreased with 40 ± 11% for phenyle-
phrine and 36 ± 16% for noradrenaline in the cultured
vessels (n = 6, P < 0.05). In the control vessels, the contrac-
tion had decreased with 30 ± 6% for phenylephrine and
21 ± 10% for noradrenaline (n = 6, P < 0.05). In contrast,
the efficacy of the U46619 contraction was unchanged
when maintained for 10 min (contraction decrease after
10 min = 5.4 ± 3% for control and 2.5 ± 2% for cultured
vessels, n = 6, P = n.s.). Also, U46619 elicited a contraction
of the same efficacy in control and cultured arteries (Emax
= 5.1 ± 0.6 mN control and 5.9 ± 1.7 mN cultured, n = 6,
P = n.s.). U46619 was therefore used as preconstrictor in
the dilatory experiments.
NO-mediated dilatation
The efficacy of the NO-mediated ACh-dilatation, studied
in the presence of indomethacin, charybdotoxin and
apamin, was significantly decreased after organ culture,
while the NO-donor SNP induced similar relaxations in
control and cultured arterial segments (Table 1, Fig. 1).
These results suggest that the NO-release from the en-
dothelium is decreased while the smooth muscle cell dil-
atory response to NO is intact.
Prostaglandin-mediated dilatation
The prostaglandin-mediated ACh-dilatation, examined in
the presence of charybdotoxin, apamin and L-NOARG,
was abolished after organ culture (Table 1, Fig. 1). The
adenylate cyclase stimulator, forskolin, relaxed cultured
and control arterial segments with the same potency and
efficacy (Table 1), indicating that the dilatory response to
prostaglandins in the smooth muscle cells is intact.
EDHF-mediated and total dilatation
Even though the NO and prostaglandin-mediated ACh-
dilatation was decreased, there was no difference in the to-
tal ACh-dilatation in control and cultured arteries without
inhibitors (Table 1, Fig. 1). This might be explained by the
finding that the ACh-induced EDHF-mediated dilatation,
studied in the presence of indomethacin and L-NOARG,
was capable of fully dilating the artery (Rmax = 83 ± 3 %,
n = 10, Table 1, Fig. 1). This response was not significantly
affected by organ culture (80 ± 3 %, n = 10, P = n.s., Table
1, Fig. 1).
When the artery segments were endothelium-denuded or
pre-treated with a combination of indomethacin, L-
NOARG, charybdotoxin and apamin, all dilatory respons-
es were abolished in both the control and the cultured ves-
sel segments. These results indicate that no other dilatory
mediator than NO, prostaglandins and EDHF was present
and that the ACh-dilatation was endothelium-dependent.
Discussion
The present study demonstrates that organ culture may be
a suitable model for studying the development of en-
dothelium dysfunction. Organ culture induces a decrease
in the NO and prostaglandin-mediated dilatation, while
EDHF serves as a backup system that preserves the capa-BMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/8
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bility of the artery to respond to a dilator. This phenotypic
change occurs in the endothelium, while the smooth mus-
cle cell function remains intact.
U46619 is a thromboxane A2 receptor agonist that was
used as precontracting agent for the following reasons:
Firstly, organ culture has been proven to induce changes
in the contractile responses to endothelin [8], serotonin
[13] and angiotensin II (unpublished data), while the
contractile responses to U46619 is unaltered. Secondly,
U46619 possess a more durable precontraction than phe-
nylephrine and noradrenaline. Stable experimental condi-
tions can in this way be established.
Figure 1
Organ culture induced changes in endothelium-derived dilatory mediators Concentration-dependent dilatations to
ACh in the U46619-precontracted rat mesenteric artery branch, before and after 20 h of organ culture. (a) NO-mediated
relaxation, studied in the presence of 10 µM indomethacin, 50 nM charybdotoxin and 1 µM apamin, was decreased after cul-
ture, n = 10, P < 0.0001. (b) Prostaglandin-mediated relaxation, studied in the presence of charybdotoxin 50 nM apamin 1 µM
and L-NOARG 0.1 mM was abolished after organ culture, n = 10, P < 0.0001. (c) EDHF-mediated relaxation, studied in the
presence of indomethacin and L-NOARG, did not change after organ culture, n = 10, P = n.s. (d) The total dilatory response to
ACh was unaltered by organ culture, n = 10, P = n.s. Data are shown as means ± S.E.M. of 10 experiments.
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The NO-mediated ACh-dilatation was decreased after or-
gan culture (Fig. 1). Equally efficient responses to the en-
dothelium-independent NO-donor SNP were observed in
cultured and control endothelium-denuded artery seg-
ments, indicating intact smooth muscle cell relaxant re-
sponsiveness. Similar changes have been observed in
cardiovascular diseases like atherosclerosis and hypercho-
lesterolemia: The NO release from the endothelium is im-
paired while the response to exogenous applied NO is
preserved [17].
The prostaglandin-mediated ACh-dilatation was abol-
ished after organ culture (Fig. 1). This effect was also en-
dothelium-dependent since forskolin induced a similar
dilatory response in control and cultured artery segments.
Forskolin activates adenylate cyclase directly in the
smooth muscle cells and thereby mimics the dilatory
pathways that are activated by prostaglandins [5]. The
smooth muscle cell response to the prostaglandins, which
are released from the endothelium, is the net effect of the
prostaglandins that induce relaxation and those that in-
duce contraction. Subsequently, the decreased prostaglan-
din-mediated dilatation in the present study may either be
due to a reduction in the release of dilatory prostaglandins
or a relative increase in the release of contractile prostag-
landins. Increased release of contractile prostaglandins
such as prostaglandin H2 and thromboxane A2 has been
observed in hypertension [18] and diabetes [19].
Acetylcholine induces dilatation by release of NO, pros-
taglandins and EDHF. No other mediator was involved
since a combination of L-NOARG, indomethacin, charyb-
dotoxin and apamin completely abolished the ACh-in-
duced relaxant response.
Table 1: Vasodilator responses after organ culture
n pEC50 (-log M) P Rmax (%) P
ACh Control 10 7.5 ± 0.2 } n.s. 93 ± 1}  n . s .
Cultured 10 7.1 ± 0.1 93 ± 3
ACh, NO-mediated Control 10 7.2 ± 0.2 } n.s. 84 ± 6 } <0.0001
Cultured 10 7.1 ± 0.2 36 ± 6
ACh, prostaglandin-
mediated
Control 10 6.1 ± 0.4 } n.s. 48 ± 7}  < 0 . 0 0 1
Cultured 10 6.6 ± 0.4 16 ± 4
ACh, EDHF-medi-
ated
Control 10 7.1 ± 0.2 } n.s. 83 ± 3}  n . s .
Cultured 10 6.1 ± 0.5 80 ± 3
Forskolin Control 7 7.1 ± 0.2 } n.s. 95 ± 1}  n . s .
Cultured 7 7.3 ± 0.2 97 ± 2
SNP Control 9 8.8 ± 0.1 } n.s. 96 ± 1}  n . s .
Cultured 9 8.9 ± 0.2 93 ± 4
Vasodilatation was assessed by cumulative addition of ACh, forskolin or SNP in the precontracted mesenteric artery branch, before and after organ 
culture for 20 h. NO-dilatation was studied in the presence of indomethacin (10 µM), charybdotoxin (50 nM) and apamin (1 µM); prostaglandin-dil-
atation in the presence of L-NOARG (0.1 mM), charybdotoxin and apamin; and EDHF-dilatation in the presence of indomethacin and L-NOARG. 
Dilatory responses are expressed as percentage of a precontraction induced by U46619. n denotes the number of experiments (animals). Statistical 
significance is expressed as P. Data are given as mean values ± S.E.M.
Figure 2
The relative contribution of the endothelium-derived
mediators to the total dilatation Schematic illustration
of the respective shares of NO, prostaglandins (PG) and
EDHF in the ACh-stimulated vasodilatation, before and after
organ culture, calculated as percent of the total dilatation
induced by ACh, based on the maximum contraction for
each mediator. In control arteries, 39 % of the dilatation was
mediated by NO, 22 % by prostaglandins and 39 % by EDHF.
In cultured arteries, 27 % of the dilatation was mediated by
NO, 12 % by prostaglandins and 61 % by EDHF.
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Although the release of prostaglandins and NO was sub-
stantially decreased after organ culture, the maximum dil-
atory response to ACh was unchanged. EDHF induced a
maximum dilatation of the artery even after organ culture
(80% before and 83% after organ culture). It can therefore
be expected that the smooth muscle cell response to
EDHF is functioning normally after culture, although
there is no proof of this since a K+ channel opener was not
used in the present experiments. EDHF seems to be more
resistant to the phenotypic change of the endothelium
and served as a backup dilatory system when NO and
prostaglandins failed. After organ culture, EDHF account-
ed for the major part of the mediators that were released
from the endothelium. The share of the total ACh-dilata-
tion that is mediated by NO, prostaglandins and EDHF re-
spectively is illustrated in figure 2.
After organ culture, the EDHF-mediated dilatation
amounted to 80 %, NO to 84 % and prostaglandins to 16
% of preconstriction. The additive NO, prostaglandin and
EDHF responses thus exceeded the total ACh-dilatation
by far. Rather than functioning in an additive way, NO,
prostaglandins and EDHF might provide separate systems
that are capable of fully dilating the blood vessel inde-
pendently. This may be a reserve mechanism, where one
factor is backup for the other if affected by pathological
conditions like endothelium dysfunction in congestive
heart failure [1,2,20,21].
When the endothelium is malfunctioning in cardiovascu-
lar disease, EDHF compensates for the increased vascular
tone elicited by a decreased NO synthesis. This compensa-
tory mechanism has mainly been observed in small resist-
ance arteries where EDHF is abundant [22]. Conversely, in
larger conduction arteries, EDHF is virtually absent and
the decreased NO release is not compensated for, result-
ing in a reduced response to various dilators. The present
study has been performed on the rat mesenteric artery
branch, which in many ways is a representative model of
a peripheral resistance vessel [23]. In this artery, the NO
and prostaglandin mediated dilatation was substantially
decreased, while a maximum EDHF-dilatation was pre-
served and served as a backup dilatory system. Similar
changes have been seen when endothelium dysfunction is
developed in small arteries [2,3,17,20,22]. Organ culture
of the rat mesenteric artery branch may therefore be a suit-
able model for endothelium dysfunction in resistance ar-
teries.
Conclusions
Organ culture induces a decrease in the NO and prostag-
landin-mediated dilatation, while EDHF serves as a back-
up system to preserve the capability of the artery to
respond to a dilator. This phenotypic change occurs in the
endothelium, while the smooth muscle cell function re-
mains intact. Similar changes have been observed when
endothelium dysfunction is developed in cardiovascular
diseases like hypertension [1], diabetes [3], hypercholiste-
rolemia [2] and congestive heart failure [20]. Organ cul-
ture may therefore provide an experimental model in
which the development of endothelium dysfunction can
be studied in detail to further delineate the mechanisms of
action. Culture in the presence of the different humoral
factors or intracellular messenger inhibitors may reveal
important pathways that lead to the development of en-
dothelium dysfunction. The method thereby combines
the advantage of cell culturing techniques with the advan-
tage of functional evaluation of intact blood vessels.
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